BIO-TECHNE Corp's diluted shares was 157M shares for fiscal year 2026 (the twelve months to 30 Jun 2026), down 1.7% from fiscal 2025.
In the first quarter of fiscal 2027 (the three months to 30 Sep 2026) it was 158M shares, up 1.0% from a year earlier.
From BIO-TECHNE Corp's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 6 Nov 2026.
Fiscal 2026
157M
−1.7%
Q1 FY2027
158M
+1.0% on a year
Growth over 9 years
+0.5%
a year, FY 2017–FY 2026
Diluted shares by fiscal year
Change on the year before, under each year. From FY 2017 to FY 2026, BIO-TECHNE Corp's diluted shares went from 150M shares to 157M shares, a compound annual change of +0.5%; the highest was 164M shares in FY 2022.
BIO-TECHNE Corp diluted shares, fiscal years
Period
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Diluted shares
150M
152M
156M
158M
162M
164M
162M
161M
160M
157M
Period end
30 Jun 2017
30 Jun 2018
30 Jun 2019
30 Jun 2020
30 Jun 2021
30 Jun 2022
30 Jun 2023
30 Jun 2024
30 Jun 2025
30 Jun 2026
Diluted shares by quarter
The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.
BIO-TECHNE Corp diluted shares, fiscal quarters
Period
Q2 FY2025
Q3 FY2025
Q4 FY2025
Q1 FY2026
Q2 FY2026
Q3 FY2026
Q4 FY2026
Q1 FY2027
Diluted shares
161M
159M
157M
156M
157M
157M
157M
158M
Period end
31 Dec 2024
31 Mar 2025
30 Jun 2025
30 Sep 2025
31 Dec 2025
31 Mar 2026
30 Jun 2026
30 Sep 2026
How diluted shares is measured
Diluted shares is the weighted average number of shares outstanding in the period, counting the shares that options, warrants and convertible securities could add; it is the count earnings per share is divided by. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.
BIO-TECHNE Corp's other figures
Diluted shares of comparable companies
Everything on TECH, in the terminal.
Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.